1	Ampicillin-resistant	Ampicillin-resistant	B-NP	JJ	O	5	NMOD
2	Haemophilus	Haemophilus	I-NP	NN	O	5	NMOD
3	influenzae	influenzae	I-NP	NN	O	5	NMOD
4	type	type	I-NP	NN	O	5	NMOD
5	B	B	I-NP	NN	O	0	ROOT
6	possessing	possess	B-VP	VBG	O	5	NMOD
7	a	a	B-NP	DT	O	9	NMOD
8	TEM-type	TEM-type	I-NP	JJ	B-protein	9	NMOD
9	beta-lactamase	beta-lactamase	I-NP	NN	I-protein	13	NMOD
10	but	but	O	CC	O	13	NMOD
11	little	little	B-NP	JJ	O	13	NMOD
12	permeability	permeability	I-NP	NN	O	13	NMOD
13	barrier	barrier	I-NP	NN	O	6	OBJ
14	to	to	B-PP	TO	O	13	NMOD
15	ampicillin	ampicillin	B-NP	NN	B-protein	14	PMOD
16	.	.	O	.	O	5	P

1	Ampicillin-resistant	Ampicillin-resistant	B-NP	JJ	O	5	NMOD
2	Haemophilus	Haemophilus	I-NP	NN	O	5	NMOD
3	influenzae	influenzae	I-NP	NN	O	5	NMOD
4	type	type	I-NP	NN	O	5	NMOD
5	B	B	I-NP	NN	O	6	SUB
6	have	have	B-VP	VBP	O	0	ROOT
7	been	be	I-VP	VBN	O	6	VC
8	reported	report	I-VP	VBN	O	7	VC
9	only	only	B-ADVP	RB	O	8	VMOD
10	during	during	B-PP	IN	O	8	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	past	past	I-NP	JJ	O	13	NMOD
13	year	year	I-NP	NN	O	10	PMOD
14	.	.	O	.	O	6	P

1	Five	Five	B-NP	CD	O	3	NMOD
2	clinical	clinical	I-NP	JJ	O	3	NMOD
3	isolates	isolate	I-NP	NNS	O	10	SUB
4	from	from	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	8	NMOD
6	U.S.	U.S.	I-NP	NNP	O	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	Germany	Germany	I-NP	NNP	O	4	PMOD
9	all	all	O	DT	O	8	NMOD
10	had	have	B-VP	VBD	O	0	ROOT
11	the	the	B-NP	DT	O	13	NMOD
12	TEM-type	TEM-type	I-NP	JJ	B-protein	13	NMOD
13	beta-lactamase	beta-lactamase	I-NP	NN	I-protein	10	OBJ
14	which	which	B-NP	WDT	O	13	NMOD
15	is	be	B-VP	VBZ	O	14	SBAR
16	known	know	I-VP	VBN	O	15	VC
17	to	to	I-VP	TO	O	18	VMOD
18	be	be	I-VP	VB	O	16	VMOD
19	transferred	transfer	I-VP	VBN	O	18	VC
20	widely	widely	B-ADVP	RB	O	19	VMOD
21	among	among	B-PP	IN	O	19	VMOD
22	other	other	B-NP	JJ	O	24	NMOD
23	gram-negative	gram-negative	I-NP	JJ	O	24	NMOD
24	bacilli	bacilli	I-NP	NNS	O	21	PMOD
25	.	.	O	.	O	10	P

1	Unlike	Unlike	B-PP	IN	O	11	VMOD
2	those	those	B-NP	DT	O	3	NMOD
3	bacilli	bacilli	I-NP	NNS	O	1	PMOD
4	,	,	O	,	O	11	P
5	however	however	B-ADVP	RB	O	11	VMOD
6	,	,	O	,	O	11	P
7	the	the	B-NP	DT	O	10	NMOD
8	H.	H.	I-NP	NN	B-cell_line	10	NMOD
9	influenzae	influenzae	I-NP	NN	I-cell_line	10	NMOD
10	cell	cell	I-NP	NN	I-cell_line	11	SUB
11	had	have	B-VP	VBD	O	0	ROOT
12	very	very	B-NP	RB	O	13	AMOD
13	little	little	I-NP	JJ	O	14	NMOD
14	barrier	barrier	I-NP	NN	O	11	OBJ
15	to	to	B-PP	TO	O	14	NMOD
16	entry	entry	B-NP	NN	O	15	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	penicillins	penicillin	B-NP	NNS	B-protein	17	PMOD
19	.	.	O	.	O	11	P

1	This	This	B-NP	DT	O	3	NMOD
2	greater	great	I-NP	JJR	O	3	NMOD
3	permeability	permeability	I-NP	NN	O	11	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	the	the	B-NP	DT	O	8	NMOD
6	H.	H.	I-NP	NN	O	8	NMOD
7	influenzae	influenzae	I-NP	NN	O	8	NMOD
8	cell	cell	I-NP	NN	O	4	PMOD
9	to	to	B-PP	TO	O	8	NMOD
10	penicillins	penicillin	B-NP	NNS	O	9	PMOD
11	appeared	appear	B-VP	VBD	O	0	ROOT
12	to	to	I-VP	TO	O	13	VMOD
13	reduce	reduce	I-VP	VB	O	11	VMOD
14	the	the	B-NP	DT	O	16	NMOD
15	protective	protective	I-NP	JJ	O	16	NMOD
16	effect	effect	I-NP	NN	O	13	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	its	its	B-NP	PRP$	O	19	NMOD
19	beta-lactamase	beta-lactamase	I-NP	NN	B-protein	17	PMOD
20	,	,	O	,	O	13	P
21	in	in	B-PP	IN	O	13	VMOD
22	that	that	B-NP	DT	O	23	NMOD
23	acquisition	acquisition	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	27	NMOD
26	TEM-type	TEM-type	I-NP	JJ	B-protein	27	NMOD
27	beta-lactamase	beta-lactamase	I-NP	NN	I-protein	24	PMOD
28	increased	increase	B-VP	VBD	O	29	NMOD
29	levels	level	B-NP	NNS	O	21	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	resistance	resistance	B-NP	NN	O	30	PMOD
32	to	to	B-PP	TO	O	31	NMOD
33	penicillins	penicillin	B-NP	NNS	B-protein	32	PMOD
34	much	much	B-ADJP	RB	O	35	AMOD
35	less	less	I-ADJP	JJR	O	33	NMOD
36	for	for	B-PP	IN	O	35	AMOD
37	individual	individual	B-NP	JJ	O	38	NMOD
38	cells	cell	I-NP	NNS	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	H.	H.	B-NP	NN	O	41	NMOD
41	influenzae	influenzae	I-NP	NNS	O	39	PMOD
42	than	than	B-PP	IN	O	21	PMOD
43	for	for	B-PP	IN	O	42	PMOD
44	those	those	B-NP	DT	O	43	PMOD
45	of	of	B-PP	IN	O	44	NMOD
46	Escherichia	Escherichia	B-NP	NNP	O	47	NMOD
47	coli	coli	I-NP	NNP	O	45	PMOD
48	.	.	O	.	O	11	P

1	Large	Large	B-NP	JJ	O	2	NMOD
2	inocula	inocula	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	either	either	B-NP	DT	O	5	NMOD
5	species	species	I-NP	NN	O	3	PMOD
6	appeared	appear	B-VP	VBD	O	0	ROOT
7	highly	highly	B-ADJP	RB	O	8	AMOD
8	resistant	resistant	I-ADJP	JJ	O	6	PRD
9	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	4	NMOD
2	unusually	unusually	I-NP	RB	O	3	AMOD
3	low	low	I-NP	JJ	O	4	NMOD
4	level	level	I-NP	NN	O	17	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	resistance	resistance	B-NP	NN	O	5	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	individual	individual	B-NP	JJ	O	9	NMOD
9	cells	cell	I-NP	NNS	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	H.	H.	B-NP	NN	O	12	NMOD
12	influenzae	influenzae	I-NP	NN	O	10	PMOD
13	containing	contain	B-VP	VBG	O	12	NMOD
14	the	the	B-NP	DT	O	16	NMOD
15	TEM-type	TEM-type	I-NP	JJ	B-protein	16	NMOD
16	beta-lactamase	beta-lactamase	I-NP	NN	I-protein	13	OBJ
17	may	may	B-VP	MD	O	0	ROOT
18	have	have	I-VP	VB	O	17	VC
19	delayed	delay	I-VP	VBN	O	18	VC
20	their	their	B-NP	PRP$	O	23	NMOD
21	emergence	emergence	I-NP	NN	O	23	NMOD
22	or	or	I-NP	CC	O	23	NMOD
23	recognition	recognition	I-NP	NN	O	19	PRD
24	,	,	O	,	O	17	P
25	and	and	O	CC	O	17	VMOD
26	has	have	B-VP	VBZ	O	17	VMOD
27	unresolved	unresolve	I-VP	VBN	O	26	VC
28	clinical	clinical	B-NP	JJ	O	29	NMOD
29	implications	implication	I-NP	NNS	O	27	OBJ
30	.	.	O	.	O	17	P

